Tmunity Therapeutics' $75 million financing tops recent funding news in Philadelphia

Philadelphia-based therapeutics and genetics company Tmunity Therapeutics has secured $75 million in Series B funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced Oct. 31 and led by Andreessen Horowitz.

According to its Crunchbase profile, "Tmunity Therapeutics is developing novel products to unleash the immunological potential of T-cells to treat a wide range of disease indications. The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease."

The five-year-old startup has raised four previous funding rounds, including a $35 million Series A round in 2018.

The round brings total funding raised by Philadelphia companies in health care over the past month to $80 million, an increase of $33 million from the month before. The local healthcare industry has seen 33 funding rounds over the past year, securing a total of $321 million in venture funding.

In other local funding news, food and beverage company Because Animals announced a seed funding round on Nov. 1, led by KEEN Growth Capital.

According to Crunchbase, "The future of pet food. Nutritious, ethical food for cats and dogs using sustainable ingredients, biodegradable packaging and never, ever harming animals."

Founded in 2018, the company has raised three previous rounds, including a seed round in 2018.

This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.